US FDA may seek more authority to improve 510(k) process
This article was originally published in Clinica
Executive Summary
The US FDA’s medical device unit is considering seeking more legislative authority to strengthen its 510(k) pre-market notification process by which it clears the majority of low- and medium-risk devices.